Publication | Open Access

HPLC–MS method for the simultaneous quantification of the antileukemia drugs imatinib, dasatinib and nilotinib in human peripheral blood mononuclear cell (PBMC)

Hematological MalignancyOncologyMedicineMalignant Blood DisorderAntileukemia Drugs ImatinibImmunologyHematologyPharmacotherapyHplc–ms MethodImmunotherapyPharmacologyCancer ResearchSimultaneous Quantification